Neurocrine halts development of schizophrenia drug luvadaxistat as it fails clinical trial MD Bureau Team13 Sept 2024 3:12 PM ISTLondon: Neurocrine Biosciences said it will halt the development of its experimental drug, aimed at improving cognitive function in patients with...
Traumatic brain injury associated with increased risk of schizophrenia and bipolar disorder, reveals research Dr. Shravani Dali8 Aug 2024 6:30 AM ISTTraumatic brain injury associated with increased risk of schizophrenia and bipolar disorder, suggests a study published in the Psychiatry...
FDA approves long acting extended-release injection for treating Schizophrenia Dr. Kamal Kant Kohli31 July 2024 8:30 PM ISTThe US Food and Drug Administration has approved a new long acting monthly paliperidone palmitate (Erzofri) extended-release injectable suspension...
Long-Term Use of Paliperidone Palmitate Ensures Stability in Schizophrenia patients: JAMA Dr Riya Dave22 July 2024 10:45 PM ISTResearchers in a recent study suggest that 6-monthly paliperidone palmitate sustains stable clinical and functional outcomes long term in adult...
Antipsychotic Drugs may Increase Pneumonia Risk in Schizophrenia Patients, suggests research Jacinthlyn Sylvia13 July 2024 7:45 AM ISTA new study conducted by Jurjen Luykx and team found that antipsychotic medications like olanzapine (>=11 mg/d), quetiapine (>=440 mg/d) and...
DEXA imaging suggests link between schizophrenia and lower BMD and higher rates of fracture: Study Dr. Shravani Dali17 Jun 2024 8:00 AM ISTDEXA imaging suggests a link between schizophrenia and lower BMD and higher rates of fracture suggests a study published in Translational...
Antipsychotic drug breakthrough may help ward off side effect of weight gain, claims study Dr. Kamal Kant Kohli30 May 2024 8:45 PM ISTThousands of Australians struggle with serious mental health conditions. But when the recommended treatment involves antipsychotic medications, the...
Xanomeline and trospium chloride combination therapy effective for schizophrenia: Study Jacinthlyn Sylvia17 May 2024 9:00 PM ISTThe EMERGENT-2 trial published in The Lancet unveiled the promising efficacy and safety of KarXT, a combination of xanomeline and trospium...
Long acting olanzapine may improve symptoms in schizophrenia patients: Study Dr. Kamal Kant Kohli11 May 2024 7:30 AM ISTOnce-monthly subcutaneous injection of olanzapine (TEV-'749) may improve symptoms in patients with schizophrenia without post injection delirium...
Schizophrenia patients more prone to long hospitalizations due to non psychiatric illnesses: Study Dr. Shravani Dali9 May 2024 7:15 AM ISTSchizophrenia patients are more prone to long hospitalisations due to non-psychiatric illnesses suggests a study published in the American Psychiatric...
Battling schizophrenia for 8 years, Nair Hospital staffer jumps to death from 15th floor of apartment Kajal Rajput7 May 2024 12:00 PM ISTMumbai: A tragic incident unfolded on Monday afternoon after a 33-year-old employee of Nair Hospital in Mumbai Central died by allegedly jumping...
Novel Combination Therapy Xanomeline-Trospium Promising for Treatment of Schizophrenia: JAMA Dr Riya Dave2 May 2024 8:02 PM ISTResearchers have found that the investigational combination of xanomeline-trospium (KarXT) is effective and well-tolerated in individuals with...
